Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet
Print
Daniel Polhamus, Ph.D
Group Leader Statistics, Principal Scientist II
Metrum Research Group
Poster(s):
138: Exposure-Response Analyses of Efficacy & Safety of Trastuzumab Deruxtecan to Inform Dosing Recommendation in HER2-mutant Non-Small Cell Lung Cancer
Monday, September 9, 2024
5:00 PM – 7:00 PM
ET
